Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Franklin Covey (FC) Current Deferred Revenue (2016 - 2025)

Franklin Covey's Current Deferred Revenue history spans 15 years, with the latest figure at $96.0 million for Q4 2025.

  • For Q4 2025, Current Deferred Revenue changed 0.32% year-over-year to $96.0 million; the TTM value through Nov 2025 reached $96.0 million, changed 0.32%, while the annual FY2025 figure was $111.7 million, 10.36% up from the prior year.
  • Current Deferred Revenue for Q4 2025 was $96.0 million at Franklin Covey, down from $111.7 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $111.7 million in Q3 2025 and bottomed at $64.8 million in Q2 2021.
  • The 5-year median for Current Deferred Revenue is $85.5 million (2022), against an average of $85.3 million.
  • The largest annual shift saw Current Deferred Revenue skyrocketed 51.42% in 2021 before it dropped 21.24% in 2025.
  • A 5-year view of Current Deferred Revenue shows it stood at $65.8 million in 2021, then rose by 13.04% to $74.4 million in 2022, then grew by 12.22% to $83.5 million in 2023, then rose by 14.63% to $95.7 million in 2024, then grew by 0.32% to $96.0 million in 2025.
  • Per Business Quant, the three most recent readings for FC's Current Deferred Revenue are $96.0 million (Q4 2025), $111.7 million (Q3 2025), and $83.5 million (Q2 2025).